Blood conservation in liver transplantation: The role of aprotinin.
Porte
Robert J
RJ
Ddepartment of Surgery, Groningen University Medical Center, Groningen, The Netherlands. r.j.porte@chir.azg.nl
Hendriks
Herman G d
HG
Slooff
Maarten J h
MJ
D000933:Antifibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use; D007611:Aprotinin / Q000009:adverse effects / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control; D001803:Blood Transfusion; D006487:Hemostasis / Q000502:physiology; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D018836:Inflammation Mediators / Q000037:antagonists & inhibitors; D008099:Liver / Q000503:physiopathology; D016031:Liver Transplantation; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D012449:Safety; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use
D000933:Antifibrinolytic Agents; D006490:Hemostatics; D018836:Inflammation Mediators; D015842:Serine Proteinase Inhibitors; D007611:Aprotinin